血管抑素基因治疗Lewis肺癌移植瘤小鼠的疗效研究  被引量:3

Curative effectiveness of angiostatin gene therapy for lewis lung carcinoma xenografts in mice

在线阅读下载全文

作  者:银瑞[1] 董新伟[1] 王铮[1] 

机构地区:[1]河南省南阳市中心医院胸外科,473009

出  处:《中华实验外科杂志》2014年第12期2768-2769,共2页Chinese Journal of Experimental Surgery

摘  要:目的 探讨血管抑素基因(PAng)治疗Lewis肺癌移植瘤小鼠的效果.方法 45只Lewis肺癌移植瘤模型的小鼠,根据对肺癌移植瘤小鼠治疗方式的不同将其随机分为3组,每组小鼠15只,分别为A组(空白组)、B组(空白脂质体组)以及C组(PAng组),观察治疗前后肿瘤体积、重量的变化以及比较肺表面转移灶数目和小鼠的平均生存周期.结果 PAng组小鼠治疗21 d后的移植肿瘤体积为(189 ± 20) mm3,与A组(5 324±246) mm3、B组(5 367 ±326) mm3比较,差异均有统计学意义(P<0.05);PAng组小鼠治疗21 d后的移植肿瘤重量为(3.54 ±0.48)g,与A组(4.21 ±0.58)g、B组(4.26 ±0.59)g比较,差异均有统计学意义(P<0.05);PAng组小鼠治疗后的肺表面转移灶数目为(4.30 ±0.42)个、平均生存周期为(54.6±6.52)d,与对照组比较差异有统计学意义(P<0.05).结论 采用PAng的治疗方式具有比较理想的治疗效果.Objective To investigate the effect of angiostatin gene therapy in mice with Lewis lung cancer xenografts.Methods Forty-five mice of Lewis lung carcinoma xenograft models were randomly divided into three groups (n =15 each):group A (saline control group),group B (blank liposome group)and group C (PAng group).Tumor volume,weight change,the number of metastases on the lung surface,and the average survival of mcie were observed and compared.Results Volume of mouse transplanted tumor in PAng group [(189 ±20) mm3] was significantly lower than the control rats [A group:(5 324 ±246) mm3] ; B group:(5 367 ±326) mm3 (P 〈0.05).Weight of mouse transplanted tumor in PAng group [(3.54 ±0.48) g] was significantly lower than A group [(4.21 ±0.58) g] and B group [(4.26 ±0.59) g,P 〈 0.05].Number of pulmonary metastatic foci after PAng treatment (4.30 ± 0.42) was much fewer compared with the control rats (P 〈 0.05) ; Average survival period of mice in PAng group [(54.6 ±6.52) d] was longer than control group (P 〈 0.05).Conclusion The use of antiangiogenic gene therapy approach has the ideal therapeutic effect.

关 键 词:血管抑素基因 肺癌 肺癌移植瘤 

分 类 号:R734.2[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象